series-a
Stage
1
Investors
About
Red Queen Therapeutics develops antiviral therapeutics targeting infectious diseases including a pan-influenza program and compounds aimed at protection against SARS-CoV-2 for high-risk populations.
Explore Red Queen Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.